Literature DB >> 29588359

Antiphospholipid syndrome presenting as acute mesenteric venous thrombosis involving a variant inferior mesenteric vein and successful treatment with rivaroxaban.

Kevin Singh1, Gulam Khan2.   

Abstract

Acute mesenteric venous thrombosis (MVT) is the rarest cause of acute mesenteric ischaemia, so thrombosis of a variant inferior mesenteric vein (IMV) is especially uncommon in the setting of antiphospholipid syndrome (APS). Here, we present such a case of seronegative APS initially manifesting as an anomalous IMV thrombosis in a 76-year-old woman. Although guidelines support anticoagulation with vitamin K antagonists in these patients, we anticoagulated with rivaroxaban (a direct oral anticoagulant (DOAC)) due to patient preference, which resulted in complete clinical and endoscopic resolution. IMV thrombosis is a rare form of MVT, only two case reports describe successful anticoagulation with DOACs in the setting of MVT and none report APS as an underlying aetiology. Therefore, this case provides the opportunity to review the pathophysiology of MVT, APS and their medical management including current trends in anticoagulation. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  GI bleeding; gastroenterology; gastrointestinal system

Mesh:

Substances:

Year:  2018        PMID: 29588359      PMCID: PMC5878327          DOI: 10.1136/bcr-2017-223077

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  42 in total

1.  Mesenteric venous thrombosis: a diagnosis not to be missed!

Authors:  A M Choudhary; D Grayer; A Nelson; I Roberts
Journal:  J Clin Gastroenterol       Date:  2000-09       Impact factor: 3.062

2.  Use of Rivaroxaban for Mesenteric Vein Thrombosis Secondary to Diverticulitis: A Case Report.

Authors:  Rukma Parthvi; Sunil Mehra
Journal:  Am J Ther       Date:  2017 Sep/Oct       Impact factor: 2.688

Review 3.  Mesenteric venous thrombosis.

Authors:  Bashar Hmoud; Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2014-04-13

Review 4.  Acute mesenteric ischemia.

Authors:  J F McKinsey; B L Gewertz
Journal:  Surg Clin North Am       Date:  1997-04       Impact factor: 2.741

Review 5.  Diagnosis and classification of the antiphospholipid syndrome.

Authors:  Jose A Gómez-Puerta; Ricard Cervera
Journal:  J Autoimmun       Date:  2014-01-24       Impact factor: 7.094

Review 6.  Mesenteric venous thrombosis.

Authors:  Ashwani K Singal; Patrick S Kamath; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2013-02-27       Impact factor: 7.616

7.  Inferior mesenteric venous thrombosis that required operations: report of two cases.

Authors:  Ryusuke Ookura; Hiroyuki Masuko; Hiroyuki Ishizu; Hitoshi Nishioka; Sei Kurokawa; Shunji Muraoka; Yukifumi Kondo
Journal:  Hepatogastroenterology       Date:  2009 May-Jun

8.  Mesenteric vein thrombosis triggered by blunt abdominal trauma in a patient with the primary antiphospholipid syndrome.

Authors:  Michael Fried; Willem Van Ganse; Steven Van Avermaet
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-06       Impact factor: 2.566

Review 9.  Guidance for the management of venous thrombosis in unusual sites.

Authors:  Walter Ageno; Jan Beyer-Westendorf; David A Garcia; Alejandro Lazo-Langner; Robert D McBane; Maurizio Paciaroni
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

10.  Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies.

Authors:  Carlos Tortosa; Oscar Cabrera-Marante; Manuel Serrano; José A Martínez-Flores; Dolores Pérez; David Lora; Luis Morillas; Estela Paz-Artal; José M Morales; Daniel Pleguezuelo; Antonio Serrano
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.